PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析

◆英語タイトル:PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7723
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PT Kimia Farma (Persero) Tbk (KAEF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito – urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java. Kimia Farma is headquartered in Jakarta, Indonesia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
PT Kimia Farma (Persero) Tbk – Key Facts 6
PT Kimia Farma (Persero) Tbk – Key Employees 7
PT Kimia Farma (Persero) Tbk – Major Products and Services 8
PT Kimia Farma (Persero) Tbk – History 9
PT Kimia Farma (Persero) Tbk – Company Statement 11
PT Kimia Farma (Persero) Tbk – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 13
Section 2 – Company Analysis 14
Company Overview 14
PT Kimia Farma (Persero) Tbk – Business Description 15
Business Segment: Distribution Segment 15
Overview 15
Performance 15
Business Segment: Manufacturing Segment 15
Overview 15
Performance 15
Business Segment: Other Segment 16
Performance 16
Business Segment: Retail Segment 16
Overview 16
Performance 16
R&D Overview 16
PT Kimia Farma (Persero) Tbk – Corporate Strategy 17
PT Kimia Farma (Persero) Tbk – SWOT Analysis 18
SWOT Analysis – Overview 18
PT Kimia Farma (Persero) Tbk – Strengths 18
PT Kimia Farma (Persero) Tbk – Weaknesses 19
PT Kimia Farma (Persero) Tbk – Opportunities 20
PT Kimia Farma (Persero) Tbk – Threats 21
PT Kimia Farma (Persero) Tbk – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
PT Kimia Farma (Persero) Tbk, Recent Deals Summary 32
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
PT Kimia Farma (Persero) Tbk, Key Facts 6
PT Kimia Farma (Persero) Tbk, Key Employees 7
PT Kimia Farma (Persero) Tbk, Major Products and Services 8
PT Kimia Farma (Persero) Tbk, History 9
PT Kimia Farma (Persero) Tbk, Other Locations 12
PT Kimia Farma (Persero) Tbk, Subsidiaries 12
PT Kimia Farma (Persero) Tbk, Joint Venture 13
PT Kimia Farma (Persero) Tbk, Key Competitors 22
PT Kimia Farma (Persero) Tbk, Ratios based on current share price 23
PT Kimia Farma (Persero) Tbk, Annual Ratios 24
PT Kimia Farma (Persero) Tbk, Annual Ratios (Cont...1) 25
PT Kimia Farma (Persero) Tbk, Annual Ratios (Cont...2) 26
PT Kimia Farma (Persero) Tbk, Interim Ratios 28
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
PT Kimia Farma (Persero) Tbk, Recent Deals Summary 32
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
PT Kimia Farma (Persero) Tbk, Performance Chart (2013 - 2017) 27
PT Kimia Farma (Persero) Tbk, Ratio Charts 29
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

★海外企業調査レポート[PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oil and Natural Gas Corporation Limited:企業の戦略・SWOT・財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Finastra Group Holdings Limited:企業の戦略・SWOT・財務情報
    Finastra Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Finastra Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sarku Japan:企業の戦略・SWOT・財務情報
    Sarku Japan - Strategy, SWOT and Corporate Finance Report Summary Sarku Japan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Westar Energy Inc:企業の発電所・SWOT分析2018
    Westar Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • OGE Energy Corp:企業の戦略・SWOT・財務情報
    OGE Energy Corp - Strategy, SWOT and Corporate Finance Report Summary OGE Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Seven-Eleven Japan Co., Ltd.:企業の戦略・SWOT・財務情報
    Seven-Eleven Japan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven-Eleven Japan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Valbiotis SAS (ALVAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Valbiotis SAS (Valbiotis) is a biotechnology company that develops novel solutions to help prevent cardiometabolic diseases, besides nutrition products. It develops solutions to prevent type 2 diabetes, non-alcoholic steatohepatitis (NASH), obesity and cardiovascular diseases. The company ha …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Dassault Systemes SA:企業の戦略・SWOT・財務情報
    Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report Summary Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Ecclesiastical Insurance Office plc:戦略・SWOT・企業財務分析
    Ecclesiastical Insurance Office plc - Strategy, SWOT and Corporate Finance Report Summary Ecclesiastical Insurance Office plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • JAMCO Corporation:企業の戦略・SWOT・財務情報
    JAMCO Corporation - Strategy, SWOT and Corporate Finance Report Summary JAMCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tuas Power Ltd:企業の戦略的SWOT分析
    Tuas Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Atox Bio Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atox Bio Ltd (Atox Bio) is a late state biotechnology company that develops immunomodulators to treat critically ill patients with severe infections. The company develops drugs for patients suffering from necrotizing soft tissue infections, a flesh eating bacteria. It implements novel mode o …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Nuvo Pharmaceuticals Inc (NRI):企業の財務・戦略的SWOT分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • AB Volvo:戦略・SWOT・企業財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Arsenal Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Medimetriks Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medimetriks Pharmaceuticals Inc (MPI) is a specialty pharmaceutical company that offers skincare products. The company provides personal care products such as cleansers, nutritional supplements, cosmetic creams, topical suspension, ointment, topical solution, and moisturizer. It offers produ …
  • Parkway Pantai Ltd:企業の戦略的SWOT分析
    Parkway Pantai Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆